Estudios originales
Published on 24 de septiembre de 2024 | http://doi.org/10.5867/medwave.2024.08.2923
Fulvestrant in clinical practice: Effectiveness analysis in Uruguayan patients with HR+/HER2- breast cancer
Back to article
Basal, pathological, and biological characteristics of the patients.
| < 65 years | 553 | 51 | |
| ≥ 65 years | 532 | 49 | |
| Male | 13 | 1.2 | |
| Female | 1072 | 98.8 | |
| Montevideo | 556 | 51.2 | |
| Canelones | 178 | 16.4 | |
| Rest of the country | 351 | 32.4 | |
| I | 6 | 0.6 | |
| II | 8 | 0.7 | |
| III | 12 | 1.1 | |
| IV | 1031 | 95 | |
| No data | 28 | 2.6 | |
| Positive | 903 | 83.2 | |
| Negative | 27 | 2.5 | |
| No data | 155 | 14.3 | |
| Positive | 764 | 70.4 | |
| Negative | 134 | 12.4 | |
| No data | 187 | 17.2 | |
| Bone | 850 | 78.3 | |
| Pulmonary | 257 | 23.7 | |
| Liver | 190 | 17.5 | |
| Other | 212 | 19.5 | |
| Exclusive bone | 455 | 41.9 | |
| Exclusive cutaneous-subcutaneous | 42 | 3.8 | |
| Exclusive pulmonary | 30 | 2.8 | |
| Exclusive hepatic | 21 | 1.9 | |
| CNS exclusive | 4 | 0.36 | |
| Smoking | 53 | 4.9 | |
| Alcoholism | 2 | 0.2 | |
| No addictions | 1030 | 94.9 | |
| 0 | 692 | 63.8 | |
| 1 | 243 | 22.4 | |
| 2 | 19 | 1.8 | |
| No data | 131 | 12 |
CNS, central nervous system; ECOG, East Cooperative Oncology Group scale.
1 Stage at disease diagnosis.
Source: Prepared by the authors of this study.